Trends in relative survival for ovarian cancer from 1975 to 2011.
about
Payment Reform: Unprecedented and Evolving Impact on Gynecologic OncologyRecreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association ConsortiumRadiation for persistent or recurrent epithelial ovarian cancer: a need for reassessment.Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancerUtilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer.Utilization and Toxicity of Alternative Delivery Methods of Adjuvant Chemotherapy for Ovarian Cancer.Asiatic acid exerts anticancer potential in human ovarian cancer cells via suppression of PI3K/Akt/mTOR signalling.Improving outcomes for older women with gynaecological malignancies.Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments.The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.Molecular Connections of Aging and Cancer.Oncofertility in gynecologic oncology: an oxymoron?Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.Statin use is associated with improved survival in ovarian cancer: A retrospective population-based study.Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.Fertility preservation and survival among young women with early ovarian cancer living in US counties with gynecologic oncologist services.Improvement in sexual function after ovarian cancer: Effects of sexual therapy and rehabilitation after treatment for ovarian cancer.Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.First-line treatment of ovarian cancer: questions and controversies to address.Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.Histopathological Pattern and Age Distribution, of Malignant Ovarian Tumor among Sudanese Ladies.Prognostic factors in epithelial ovarian cancer: A population-based study.Changes in ovarian cancer survival during the 20 years before the era of targeted therapy.
P2860
Q26752395-AEA798B7-74CA-4572-9001-A263D7E44ED9Q30276610-5676EB34-E648-406A-BF7B-11FE8CC97214Q33919697-E5279751-12D3-4E9F-86E0-CEE031F0DD58Q36326939-BF3588AB-2AB3-48A7-9DBC-529537AA37D1Q36855239-C9BFCA4B-3E33-4A18-9705-DC73802967CFQ36932557-EA6507EE-0EEF-40B0-8575-C55632ABA270Q36932625-4C4AA0D5-9ECF-44CB-B588-EA915ED9B8C8Q38785763-99DE3DC7-DE34-49AF-87FB-DBA401E0D8C9Q38963512-D6DB33C3-EFC0-41DC-93F2-AC5A5A07E4BEQ42099922-70FA9451-4918-460C-9483-009459C7DE8CQ42278865-9B1AD072-44AC-4362-A330-AA01D0C94D70Q42364242-E771167F-A723-4163-A5B7-8B1B0B698910Q44159707-711ABBDC-32C0-4E3D-8D40-10C1CB34132BQ46538048-C580BCE7-FD4A-497F-8ACD-57B599CF8921Q47119934-10889D9E-363F-4301-BAB4-2A9B108F6D19Q47368363-7A7E2ED3-D6D1-4F6B-8D9F-B394E73344BFQ47443109-B3AB8B2E-F0F0-4D34-8B74-F70F0422C1FFQ47552154-7788EF82-8BF6-48C9-BEA0-7DC6EFB36CE3Q48110433-0C06D3A3-A5AC-4C95-A159-3DC186320DA4Q52584387-94CC5805-9ABF-4364-A84D-8464A97C84DCQ53048880-366ADF21-D41F-479E-B940-54DAF5627103Q53838108-E83B13FD-D6A1-4E7D-82CA-F668B1DCF95FQ55315651-B7DAA60F-5589-4D46-8529-DE388DB89B29Q55366217-6143F0D2-DD47-46B9-ADC4-4760F714BF97
P2860
Trends in relative survival for ovarian cancer from 1975 to 2011.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Trends in relative survival for ovarian cancer from 1975 to 2011.
@ast
Trends in relative survival for ovarian cancer from 1975 to 2011.
@en
type
label
Trends in relative survival for ovarian cancer from 1975 to 2011.
@ast
Trends in relative survival for ovarian cancer from 1975 to 2011.
@en
prefLabel
Trends in relative survival for ovarian cancer from 1975 to 2011.
@ast
Trends in relative survival for ovarian cancer from 1975 to 2011.
@en
P2093
P2860
P1476
Trends in relative survival for ovarian cancer from 1975 to 2011.
@en
P2093
Alfred I Neugut
Ana I Tergas
Cande V Ananth
Jason D Wright
June Y Hou
Sonali Patankar
William M Burke
P2860
P304
P356
10.1097/AOG.0000000000000854
P407
P577
2015-06-01T00:00:00Z